Tumor-associated macrophages (TAMs) are originated from inflammatory monocytes or M-MDSCs (monocytic myeloid-derived suppressor cells) that are directed to the TME by chemoattractants secreted from cancer cells or tumor-associated cells (e.g., CCL2, CCL5, and CSF1). This evidence concerns the gene CCL5 and neoplasm.